Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 ...
The Biden administration started two programs during the pandemic to help states and tribes purchase local food from nearby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results